MEDVi review

What I actually think of MEDVi

MEDVi, LLC received FDA warning letter MARCS-CMS 721455 in February 2026 over claims about its compounded semaglutide and tirzepatide. MEDVi’s public treatment page displays unresolved price placeholders for compounded semaglutide. Its brand-name Wegovy and Zepbound options require $99 membership plus medication. A complete current medication total could not be confirmed.

I look at MEDVi the way moms actually have to — not just the real monthly number, but nursing and pregnancy timing and canceling without a fight. That's the stuff a generic weight-loss review skips right over.

What MEDVi really costs

A confirmed monthly cash price for the exact medication and formulation is not established here. Get the product, supply length, full charge and renewal rate in writing before paying. If a clear, upfront price is what you're after, my cheapest-first shortlist is a useful comparison.

Which meds MEDVi prescribes

MEDVi prescribes tirzepatide, a dual GIP/GLP-1 receptor agonist. Its suitability depends on an individual clinical assessment. It can also route you to FDA-approved brand pens, not just compounded — and the on-label products come with the manufacturer's own pregnancy and lactation labeling, which is a lot cleaner to hand to your OB.

There's a needle-free option here too, and it's worth asking exactly which kind before you choose it. An FDA-approved GLP-1 tablet is a studied medicine with its own label; a compounded under-the-tongue version is a different thing, far less studied than the shots the trials actually used. They get advertised in almost identical language.

Who MEDVi is — and isn't — for

A good fit if…

• you want a no-nonsense tirzepatide program and you'll confirm the details before you commit.

Look elsewhere if…

• a clean regulatory record is a dealbreaker — read the FDA warning I flagged in the caveats above first.
• you want to compare another option before deciding — review the published terms and support offered by CoreAge Rx, our featured partner, alongside this provider.

Can you trust it?

My confidence is middling — the core facts hold up, but some details (per-state availability, how the program really runs) aren't fully public. And it's carrying an FDA warning letter, which I flagged in the caveats — read that before you start. With any compounded GLP-1, the most useful thing you can do is confirm which licensed pharmacy fills it and what's actually in the formulation — I explain how I weigh oversight in the scoring method.

Pregnancy planning and breastfeeding need advice for the exact product, formulation and indication. Injectable and oral products have different lactation wording. The breastfeeding evidence guide explains the limited data; decide timing with your prescriber and pediatrician.

So, would I use it?

MEDVi is a provider I only list with the warnings attached — weigh it against the picks below on nursing and pregnancy timing and canceling without a fight. If you want a second option, CoreAge Rx is our featured partner — you can see them side by side in this head-to-head.